Biocon: Launching a New Cancer Drug in India

Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India.
Collection: HBSP (USA)
Ref: HBS-508026-E
Format: PDF
Number of pages: 15
Publication Date: Aug 28, 2007
Language: English
Review date: Nov 26, 2008

What material is included in this case:

Other supplements

Description

Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India.
Read more
Year: Event Year Start:2006
Geographic Setting: Geographic Setting:India
Industry Setting: Industry Setting:Biotechnology

Biocon: Launching a New Cancer Drug in India

Options of use
Number of copies
- +
As low as €8.53

Are you interested in this product?

Add it to your favourites so that your institution can purchase it.
You'll be able to order once your profile has been validated.
Add to wishlist

Leave your rating

"Biocon: Launching a New Cancer Drug in India"